Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.
about
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS studyCharacteristics of Tau and Its Ligands in PET ImagingClinicopathologic assessment and imaging of tauopathies in neurodegenerative dementiasDifferentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.Magnetic resonance imaging in progressive supranuclear palsy.Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body DisordersAssessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy.Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.Imaging correlates of pathology in corticobasal syndrome.A disease-specific metabolic brain network associated with corticobasal degeneration.The pathological basis of semantic dementia.TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia.Is synaptic loss a unique hallmark of Alzheimer's disease?Disease specificity and pathologic progression of tau pathology in brainstem nuclei of Alzheimer's disease and progressive supranuclear palsyNeuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP?Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathyNeuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndromeTau assembly in inducible transfectants expressing wild-type or FTDP-17 tau.Signature tau neuropathology in gray and white matter of corticobasal degenerationRequired techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases.Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials.Clinical correlates of white matter tract degeneration in progressive supranuclear palsy.TOC1: characterization of a selective oligomeric tau antibody.Morphometry of the human substantia nigra in ageing and Parkinson's disease.Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD.Characterization of Early Pathological Tau Conformations and Phosphorylation in Chronic Traumatic Encephalopathy.Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremorVoxel-based morphometry in autopsy proven PSP and CBDNeuropsychological findings in clinically atypical autopsy confirmed corticobasal degeneration and progressive supranuclear palsyRates of cerebral atrophy differ in different degenerative pathologies.Different molecular pathologies result in similar spatial patterns of cellular inclusions in neurodegenerative disease: a comparative study of eight disordersNovel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration.Altered sleep and EEG power in the P301S Tau transgenic mouse model.Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathies.Visual signs and symptoms of progressive supranuclear palsy.Corticobasal degeneration: a pathologically distinct 4R tauopathy.Neuropathological background of phenotypical variability in frontotemporal dementia.Extrapyramidal syndromes in frontotemporal degeneration.
P2860
Q24655620-EDD773D5-8387-44B7-8972-8CD3C5548522Q26769952-A499555D-B29A-4AA7-8BC3-D02A4D83220DQ27003078-539E5E3F-F458-4476-9B34-AC4C52E72CF7Q30588544-A552B481-40FF-4C47-8893-1681DA99B8EDQ33779124-EC352B1C-57A3-4808-8CBD-C24B442BFD9FQ33874572-E0325B9A-66A3-4A4D-8029-6671C73860EDQ33922493-D7B50BFD-3AAF-4A1D-8A1A-D5B31FB6757BQ34046590-E4473F89-2C69-46DD-B014-021D19EFAA0EQ34370058-0C843A09-C7DA-466D-BA6A-99F642CE0A75Q34399253-B3CD66DA-5CA9-4CF3-ACB7-527A2FF80571Q34431680-C8B02077-C892-47C1-8EAD-5E414B270DC8Q34455599-07E60C4C-650B-4D51-9C4B-475F179C5BB4Q34504659-EA5E705A-8360-4051-9D94-B420A6B2D332Q34604164-1EA1F17B-06C2-41B7-85FF-D24EBBCA6AE4Q35028155-E1F5BFD5-C20E-48F2-A4BC-07C37DB15F02Q35158609-D4375406-252D-47D0-8CE7-40CAC6C2AF11Q35523801-BDCBCA8D-C337-4326-BE49-15A66BEC43D4Q35540064-2215E436-9B7B-434A-98C4-C07219260148Q35747827-6CEE5684-FDBC-4A28-9278-97BACC56E218Q35747931-5C93557B-EF6D-4F33-A6BC-CCE69B19E835Q36006656-B76A5D8E-46C4-47AC-B2E7-BE71DE9AEFA1Q36101560-B03C5F5A-1167-4D98-AA00-D29777D021CEQ36107380-4F075654-8181-463B-AC13-687A4022C001Q36687306-1BD4544C-D750-4BCF-BABC-1FE6B31DB435Q36727465-3BE19930-6E1A-47E2-9ED8-453F4C242EDEQ36788234-BEE00C5E-B24E-4318-9787-41B92318DC70Q36963598-9F73CBA4-C737-4B84-9B43-6FFD4781FC88Q37046290-6D96C8AB-E4E9-47AF-A862-03E4025480EDQ37106984-F16BB1B9-BAB3-4F1D-84DB-1290F629C243Q37243463-BC022CF3-05C6-4BBC-8548-56820158CC51Q37243484-EDC1CEAC-17B6-4DB1-8921-0E8A00CE3C32Q37363768-D695DCC4-9837-4237-8A5C-B389C2DD7BBEQ37392690-AFB66A6A-D2CE-4C30-A36E-8C7121A4C8EEQ37619559-074A4F9F-8D26-45C1-9F1D-41089A1B30F4Q37681990-BF130DC6-359C-4927-A222-3B27CE6C42DEQ37691087-CFDE9D0A-21C2-4EC6-A016-72F129743A8EQ37772535-3E0A9015-EA27-44B8-8833-226D40B48765Q37864531-32D5D6FC-90ED-43D0-8E47-CF489F954EC5Q37879961-224DA81A-4AC2-4726-A2B8-8C75B3902873Q37925639-52D63DF3-9581-4C19-8854-DCD369FE43BE
P2860
Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Neuropathologic differentiatio ...... and corticobasal degeneration.
@ast
Neuropathologic differentiatio ...... and corticobasal degeneration.
@en
type
label
Neuropathologic differentiatio ...... and corticobasal degeneration.
@ast
Neuropathologic differentiatio ...... and corticobasal degeneration.
@en
prefLabel
Neuropathologic differentiatio ...... and corticobasal degeneration.
@ast
Neuropathologic differentiatio ...... and corticobasal degeneration.
@en
P2860
P356
P1433
P1476
Neuropathologic differentiatio ...... and corticobasal degeneration.
@en
P2093
Dickson DW
P2860
P2888
P304
P356
10.1007/BF03161076
P478
246 Suppl 2
P577
1999-09-01T00:00:00Z
P5875
P6179
1040014984